However, quantification of the parasite load showed highly significant differences between the respective BKI-1748 and C+ groups ( Fig. 8 B and C).
← all excerpts
In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts.
1
—
—